引導式測驗 · 中等 等級
人工智慧在腎臟疾病和腎臟病學測驗的應用
測試腎臟風險預測、AKI 和 CKD 監測之間的差異、外部驗證以及風險警報的限制。
問題 1 的 8
Which measurements does KDIGO emphasize for monitoring CKD progression?
預覽每個問題8 問題
當您參加測驗時,就會出現答案和解釋。
- Which measurements does KDIGO emphasize for monitoring CKD progression?
- A single AI risk score
- Blood pressure only
- GFR and albuminuria
- A one-time imaging result
- What does an AKI risk alert mean?
- Risk is elevated over a defined period, not that injury is certain
- Kidney injury is already confirmed
- Treatment should change automatically
- The patient no longer needs lab tests
- What kind of data may an AKI model analyze?
- Only a patient’s preferred pharmacy
- Laboratory trends and clinical record information
- Only kidney ultrasound images
- A handwritten symptom diary alone
- Why does the 495,971-admission study not establish that AI alerts improve patient outcomes?
- It randomized hospitals to receive different kidney treatments
- It measured kidney outcomes only after a prospective alert rollout
- It tested only changes in patient satisfaction
- It was a retrospective validation, not an implementation trial proving benefit
- Why test a model at hospitals different from its training site?
- To eliminate clinician training at every new hospital
- To avoid calibration checks in the local population
- To assess whether performance transports to different patients and workflows
- To add variables regardless of input quality
- What can missing baseline laboratory data do to a prediction?
- Change the inputs and reliability of the risk estimate
- Guarantee an accurate result
- Prove a patient has CKD
- Remove the need for external validation
- Which harm can follow overreacting to normal lab variation?
- Guaranteed recovery of kidney function
- Unnecessary testing or management changes
- Improved calibration
- Removal of all false negatives
- Who determines whether an AI kidney-risk alert warrants action?
- The model alone
- 軟體供應商
- 病患門戶
- The clinical care team